stocks

Micron (MU) Earnings on Tap as End of Q4 Season Approaches

Our preview of the upcoming week's earnings reports includes Micron (MU), Lululemon (LULU) and Walgreens (WBA).

Micron Technology (MU, $77.35) will headline this week's relatively bare earnings calendar, with the chipmaker slated to report its fiscal second-quarter results after Tuesday's close.

Analysts, on average, are anticipating earnings of $1.97 per share for the three-month period, up 101% on a year-over-year (YoY) basis. On the top line, the consensus estimate is for $7.5 billion – a significant improvement over the $6.2 billion MU reported in the year-ago period.

Wedbush analyst Matt Bryson recently upgraded the semiconductor stock to Outperform (Buy), saying DRAM pricing likely bottomed in the first three months of 2022. 

He believes Micron will meet or exceed fiscal second-quarter guidance. "We did not encounter any signs of MU pushing discounted inventory towards the end of the quarter, with the Boise manufacturer rather lifting terms for NAND bits as it benefitted from concerns about lost Kioxia/Western Digital (WDC) production," he says. 

For context, production at a joint Kioxia/WDC 3D NAND fabrication facility in Japan was disrupted last month by chemical contamination.

Lululemon Stock Struggles Ahead of Q4 Earnings

Lululemon Athletica (LULU, $319.51) has not been immune to broad-market headwinds, with shares down around 18% for the year-to-date.

Can a solid earnings report help the consumer discretionary stock reverse course? 

The athletic apparel maker will unveil its fourth-quarter earnings report after the March 29 close and analysts seem generally upbeat about the quarter. On average, Wall Street pros are calling for earnings of $3.28 per share (+27.1% YoY) and revenue of $2.1 billion, a 23.4% increase from year prior.

Deutsche Bank analyst Gabriella Carbone (Buy) is expecting a fourth-quarter beat and believes LULU will report above-consensus earnings of $3.31 per share, saying post-omicron sales trends improved in January.

Sign up for Kiplinger's FREE Investing Weekly e-letter for stock, ETF and mutual fund recommendations, and other investing advice.

However, she'll be watching Lululemon's first-quarter and full-year guidance, which could come in below consensus estimates. "We think ongoing transit delays in North America will lead LULU to resort to air freight, which may pressure margins to a greater degree than anticipated," Carbone writes in a note.

Walgreens Vaccine Boost Solid to Start 2022, But Should Wane

Walgreens Boots Alliance (WBA, $47.17) is the last of the Dow Jones stocks to report this earnings season, with the pharmacy chain slated to unveil its fiscal second-quarter earnings after Thursday's close.

On average, analysts are looking for a 9.5% increase in earnings to $1.38 per share and a 1.8% rise in revenue to $33.4 billion. 

"In a similar vein to last quarter, we expect a solid quarter as vaccine trends and over-the-counter testing volume related to the omicron variant are expected to yield a positive boost to earnings," says Credit Suisse analyst A.J. Rice. He has a Neutral rating on WBA, which is the equivalent of a Hold. 

Walgreens has said that every 1 million vaccines distributed contributes roughly 2 cents per share to its bottom line and Rice estimates that the company administered 10 million shots in its fiscal second quarter. Looking forward, though, the analyst believes the vaccine benefit will begin to wane. 

WBA's impending sale of its U.K. drugstore chain Boots could also be in focus when the company reports earnings. While several bidders have reportedly dropped out of the running, "headlines indicate that the sale process continues," Rice says. 

Most Popular

How to Use Your Estate Plan to Save on Taxes While You’re Still Alive!
estate planning

How to Use Your Estate Plan to Save on Taxes While You’re Still Alive!

Upstream basis planning is a trust strategy that can save wealthy people on their capital gains taxes and income taxes associated with highly apprecia…
July 3, 2022
Your Guide to Roth Conversions
Special Report
Tax Breaks

Your Guide to Roth Conversions

A Kiplinger Special Report
February 25, 2021
5 Ways to Prepare for a Recession
recession

5 Ways to Prepare for a Recession

The signs seem to be pointing in one direction these days, so if you’re worried about being ready for a recession, consider taking these five measures…
June 28, 2022

Recommended

Stock Market Today (7/1/22): Stocks Catch a Second Wind to Start Second Half
Stock Market Today

Stock Market Today (7/1/22): Stocks Catch a Second Wind to Start Second Half

Despite a dour ISM manufacturing index reading Friday, stocks broadly managed to pull themselves together and finish well in the black.
July 1, 2022
Stock Market Today (6/30/22): S&P Suffers Worst First Half Since 1970
Stock Market Today

Stock Market Today (6/30/22): S&P Suffers Worst First Half Since 1970

The major indexes produced a familiar result Thursday, finishing in the red to close out a dreary first six months of the year.
June 30, 2022
Can AI Beat the Market? 10 Stocks to Watch
stocks

Can AI Beat the Market? 10 Stocks to Watch

An artificial intelligence (AI) system identifying high-potential equities has been sharp in the past. Here are its 10 top stocks to watch over the ne…
June 30, 2022
Stock Market Today (6/29/22): Markets Steady, But Bed Bath, Cruise Lines Tumble
Stock Market Today

Stock Market Today (6/29/22): Markets Steady, But Bed Bath, Cruise Lines Tumble

The calmest market day of 2022 wasn't nearly so pleasant for a few individual stocks, including retailer BBBY and cruise operator CCL.
June 29, 2022